Abstract
A June 2012 meeting in Dublin, Ireland, showcased advances in the understanding of the role of IL-17 and related cytokines in host immunity and how these cytokines have been successfully targeted for the treatment of autoimmunity.
Publication types
-
Congress
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adaptive Immunity / drug effects
-
Animals
-
Antibodies / therapeutic use
-
Autoimmune Diseases / immunology
-
Autoimmune Diseases / therapy
-
Autoimmunity / drug effects
-
Bacterial Infections / immunology
-
Bacterial Infections / therapy
-
Humans
-
Immunity, Innate / drug effects
-
Immunologic Factors / therapeutic use*
-
Interleukin-17 / antagonists & inhibitors
-
Interleukin-17 / immunology*
-
Mice
-
Molecular Targeted Therapy*
-
Mycoses / immunology
-
Mycoses / therapy
-
Neoplasms / immunology
-
Neoplasms / therapy
-
Receptors, Interleukin-17 / antagonists & inhibitors
-
Receptors, Interleukin-17 / immunology*
-
Th17 Cells / drug effects
-
Th17 Cells / immunology
-
Virus Diseases / immunology
-
Virus Diseases / therapy
Substances
-
Antibodies
-
Immunologic Factors
-
Interleukin-17
-
Receptors, Interleukin-17